Mozart Therapeutics

Biotech · Private

Therapeutic molecules targeting regulatory T cells for autoimmune disease treatment

mozart-tx.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
24
1 granted · 23 pending
Sector median: 2

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1327Nellone Therapeutics, Inc.——
1328Prox Capital Holdings, LLC—$800K
1329Parabilis Medicines——
1330Mozart Therapeutics——
1331Knudra Diagnostics——
1332NURAVAX, INC.——
1333LEUKOSIGHT, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 1 granted of 24
  • Binding Agents And Methods Of Using The Samegranted
  • Binding Agents And Methods Of Using The Sameapplication
  • Targeted Cytokine Deliveryapplication
  • Targeted Cytokine Deliveryapplication
  • CD8-SPECIFIC Binding Proteins And Methods Of Using The Sameapplication
  • CD8-SPECIFIC Binding Proteins And Methods Of Using The Sameapplication
  • Engineered Cytokinesapplication
  • CD8-SPECIFIC Binding Proteins And Methods Of Using The Sameapplication
  • CD8-SPECIFIC Binding Proteins And Methods Of Using The Sameapplication
  • CD39-SPECIFIC Binding Agents And Methods Of Using The Sameapplication
  • CD8-SPECIFIC Binding Proteins And Methods Of Using The Sameapplication
  • CD8-SPECIFIC Binding Proteins And Methods Of Using The Sameapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.